Severe Primary Dysmenorrhea clinical trials

Explore recruiting severe primary dysmenorrhea clinical trials.

Also recruiting in Europe

Severe Primary Dysmenorrhea trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection via Hysteroscopy in pelvic pain suggestive of dysmenorrhea: A Prospective, Multicenter, Double-Blind, Randomized Placebo-Controlled Study. HYSTEROXINE Study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Severe Primary Dysmenorrhea trials by city

Severe Primary Dysmenorrhea in Toronto Severe Primary Dysmenorrhea in Vancouver Severe Primary Dysmenorrhea in Montreal Severe Primary Dysmenorrhea in Calgary Severe Primary Dysmenorrhea in Edmonton Severe Primary Dysmenorrhea in Ottawa Severe Primary Dysmenorrhea in Winnipeg Severe Primary Dysmenorrhea in Quebec City Severe Primary Dysmenorrhea in Hamilton Severe Primary Dysmenorrhea in Kitchener Severe Primary Dysmenorrhea in London Severe Primary Dysmenorrhea in Halifax Severe Primary Dysmenorrhea in New York Severe Primary Dysmenorrhea in Los Angeles Severe Primary Dysmenorrhea in Chicago Severe Primary Dysmenorrhea in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease